13 results on '"Bruce-Keller, Annadora J."'
Search Results
2. Apolipoprotein E Genotype Linked to Spatial Gait Characteristics: Predictors of Cognitive Dual Task Gait Change.
- Author
-
MacAulay, Rebecca K., Allaire, Ted, Brouillette, Robert, Foil, Heather, Bruce-Keller, Annadora J., and Keller, Jeffrey N.
- Subjects
APOLIPOPROTEIN E ,GAIT in humans ,ALZHEIMER'S disease ,COGNITION disorders ,HEALTH of older people - Abstract
Background: Developing measures to detect preclinical Alzheimer’s Disease is vital, as prodromal stage interventions may prove more efficacious in altering the disease’s trajectory. Gait changes may serve as a useful clinical heuristic that precedes cognitive decline. This study provides the first systematic investigation of gait characteristics relationship with relevant demographic, physical, genetic (Apolipoprotein E genotype), and health risk factors in non-demented older adults during a cognitive-load dual task walking condition. Methods: The GAITRite system provided objective measurement of gait characteristics in APOE-e4 “carriers” (n = 75) and “non-carriers” (n = 224). Analyses examined stride length and step time gait characteristics during simple and dual-task (spelling five-letter words backwards) conditions in relation to demographic, physical, genetic, and health risk factors. Results: Slower step time and shorter stride length associated with older age, greater health risk, and worse physical performance (ps < .05). Men and women differed in height, gait characteristics, health risk factors and global cognition (ps < .05). APOE-e4 associated with a higher likelihood of hypercholesterolemia and overall illness index scores (ps < .05). No genotype-sex interactions on gait were found. APOE-e4 was linked to shorter stride length and greater dual-task related disturbances in stride length. Conclusions: Stride length has been linked to heightened fall risk, attention decrements and structural brain changes in older adults. Our results indicate that stride length is a useful behavioral marker of cognitive change that is associated with genetic risk for AD. Sex disparities in motor decline may be a function of health risk factors. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
3. Relationship Between Cognitive Domains, Physical Performance, and Gait in Elderly and Demented Subjects.
- Author
-
Bruce-Keller, Annadora J., Brouillette, Robert M., Tudor-Locke, Catrine, Foil, Heather C., Gahan, William P., Nye, Danielle M., Guillory, Leslie, and Keller, Jeffrey N.
- Subjects
- *
COGNITIVE ability , *GAIT disorders , *COGNITION disorders , *ALZHEIMER'S disease , *ACCIDENTAL falls in old age , *WALKING - Abstract
Cognitive function declines with age, with studies linking decreases in cognitive function to increased fall risk. The association between declines in specific cognitive domains and the development of gait and physical performance deficits has not been established. The current cross-sectional study was designed to address these issues using well characterized control subjects (n = 50), and individuals with early stage dementia (n = 50) tightly matched for age, gender, and education. All participants received detailed cognitive assessments for global cognitive function, as well as for processing speed, verbal fluency, and executive function. Additionally, participants were administered single- and dual-task gait assessments (GAITRite) and Short Physical Performance Battery (SPPB) measures of physical performance (gait, balance, chair stands). Data show that all measures of cognitive function correlated significantly with measures of gait and physical performance when analyzed in all subjects or just subjects with dementia. However, data also reveal that measures of processing speed and verbal fluency correlated significantly with multiple aspects of motor performance in non-demented, control subjects, even when corrected for age. There was no correlation between global cognitive function and motor performance, and only limited relationship between executive function and motor performance in non-demented, control subjects. These studies reveal the complex interactions between cognitive function and gait/physical performance in the context of aging and dementia, and suggest that impairments in specific cognitive domains might undermine gait and physical performance and thus exacerbate fall risk in the elderly. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
4. Mutant Amyloid Precursor Protein Differentially Alters Adipose Biology under Obesogenic and Non-Obesogenic Conditions.
- Author
-
Freeman, Linnea R., Le Zhang, Dasuri, Kalavathi, Fernandez-Kim, Sun-Ok, Bruce-Keller, Annadora J., Keller, Jeffrey N., and Reddy, Hemachandra
- Subjects
AMYLOID beta-protein precursor ,ALZHEIMER'S disease ,ADIPOSE tissues ,OBESITY ,TRIGLYCERIDES ,AMYLOID beta-protein - Abstract
Mutations in amyloid precursor protein (APP) have been most intensely studied in brain tissue for their link to Alzheimer's disease (AD) pathology. However, APP is highly expressed in a variety of tissues including adipose tissue, where APP is also known to exhibit increased expression in response to obesity. In our current study, we analyzed the effects of mutant APP (E693Q, D694N, K670N/M671L) expression toward multiple aspects of adipose tissue homeostasis. These data reveal significant hypoleptinemia, decreased adiposity, and reduced adipocyte size in response to mutant APP, and this was fully reversed upon high fat diet administration. Additionally, mutant APP was observed to significantly exacerbate insulin resistance, triglyceride elevations, and macrophage infiltration of adipose tissue in response to a high fat diet. Taken together, these data have significant implications for linking mutant APP expression to adipose tissue dysfunction and global changes in endocrine and metabolic function under both obesogenic and non-obesogenic conditions. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
5. Cognitive impairment in humanized APP×PS1 mice is linked to Aβ1–42 and NOX activation
- Author
-
Bruce-Keller, Annadora J., Gupta, Sunita, Knight, Alecia G., Beckett, Tina L., McMullen, Jessica M., Davis, Paulina R., Murphy, M. Paul, Van Eldik, Linda J., St Clair, Daret, and Keller, Jeffrey N.
- Subjects
- *
COGNITION disorders , *LABORATORY mice , *ALZHEIMER'S disease , *AMYLOID , *OXIDATIVE stress , *ENZYMES , *OXIDATION-reduction reaction , *DEMENTIA - Abstract
Abstract: Cognitive impairment in Alzheimer''s disease (AD) is strongly associated with both extensive deposition of amyloid β peptides and oxidative stress, but the exact role of these indices in the development of dementia is not clear. This study was designed to determine the relationship between cognitive impairment, activation of the free radical producing enzyme NADPH oxidase (NOX), and progressive changes in Aβ deposition and solubility in humanized APP×PS1 knock-in mice of increasing age. Data show that cognitive performance and expression of key synaptic proteins were progressively decreased in aging APP×PS1 mice. Likewise, NOX activity and expression of the specific NOX subunit NOX4 were significantly increased in APP×PS1 mice in an age-dependent manner, and NOX activity and cognitive impairment shared a significant linear relationship. Data further show that age-dependent increases in Aβ1–42 had a significant linear relationship with both NOX activity and cognitive performance in APP×PS1 knock-in mice. Collectively, these data show that NOX expression and activity are significantly upregulated with age in this humanized model of Aβ pathogenesis, and suggest that NOX-associated redox pathways are intimately linked to both the loss of cognitive function and the deposition of Aβ1–42. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
6. Neuron Specific Toxicity of Oligomeric Amyloid-β: Role for JUN-Kinase and Oxidative Stress.
- Author
-
Ebenezer, Philip J., Weidner, Adam M., LeVine III, Harry, Markesbery, William R., Murphy, M. Paul, Le Zhang, Dasuri, Kalavathi, Fernandez-Kim, Sun Ok, Bruce-Keller, Annadora J., Gavilán, Elena, and Keller, Jeffrey N.
- Subjects
NEURONS ,AMYLOID beta-protein ,OXIDATIVE stress ,PROTEINS ,OXIDATION - Abstract
Recent studies have demonstrated a potential role for oligomeric forms of amyloid-β (Aβ) in the pathogenesis of Alzheimer's disease (AD), although it remains unclear which aspects of AD may be mediated by oligomeric Aβ. In the present study, we found that primary cultures of rat cortical neurons exhibit a dose-dependent increase in cell death following Aβ oligomer administration, while primary cultures of astrocytes exhibited no overt toxicity with even the highest concentrations of oligomer treatment. Neither cell type exhibited toxicity when treated by equal concentrations of monomeric Aβ. The neuron death induced by oligomer treatment was associated with an increase in reactive oxygen species (ROS), altered expression of mitochondrial fission and fusion proteins, and JUN kinase activation. Pharmacological inhibition of JUN kinase ameliorated oligomeric Aβ toxicity in neurons. These data indicate that oligomeric Aβ is sufficient to selectively induce toxicity in neurons, but not astrocytes, with neuron death occurring in a JUN kinase-dependent manner. Additionally, these observations implicate a role for oligomeric Aβ as a contributor to neuronal oxidative stress and mitochondrial disturbances in AD. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
7. Effects of short-term Western diet on cerebral oxidative stress and diabetes related factors in APP × PS1 knock-in mice.
- Author
-
Studzinski, Christa M., Li, Feng, Bruce-Keller, Annadora J., Fernandez-Kim, Sun Ok, Zhang, Le, Weidner, Adam M., Markesbery, William R., Murphy, M. Paul, and Keller, Jeffrey N.
- Subjects
ALZHEIMER'S disease risk factors ,DIET in disease ,OXIDATIVE stress -- Risk factors ,AMYLOID beta-protein ,DIET research - Abstract
A chronic high fat Western diet (WD) promotes a variety of morbidity factors although experimental evidence for short-term WD mediating brain dysfunction remains to be elucidated. The amyloid precursor protein and presenilin-1 (APP × PS1) knock-in mouse model has been demonstrated to recapitulate some key features of Alzheimer’s disease pathology, including amyloid-β (Aβ) pathogenesis. In this study, we placed 1-month-old APP × PS1 mice and non-transgenic littermates on a WD for 4 weeks. The WD resulted in a significant elevation in protein oxidation and lipid peroxidation in the brain of APP × PS1 mice relative to non-transgenic littermates, which occurred in the absence of increased Aβ levels. Altered adipokine levels were also observed in APP × PS1 mice placed on a short-term WD, relative to non-transgenic littermates. Taken together, these data indicate that short-term WD is sufficient to selectively promote cerebral oxidative stress and metabolic disturbances in APP × PS1 knock-in mice, with increased oxidative stress preceding alterations in Aβ. These data have important implications for understanding how WD may potentially contribute to brain dysfunction and the development of neurodegenerative disorders such as Alzheimer’s disease. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
8. ANALYSIS OF GENE EXPRESSION IN NEURAL CELLS SUBJECT TO CHRONIC PROTEASOME INHIBITION
- Author
-
Ding, Qunxing, Bruce-Keller, Annadora J., Chen, Qinghua, and Keller, Jeffrey N.
- Subjects
- *
GENE expression , *FREE radicals , *ALZHEIMER'S disease , *PARKINSON'S disease - Abstract
A number of studies have suggested that proteasome inhibition plays a causal role in the neuropathological processes observed in aging, Alzheimer''s disease (AD), and Parkinson''s disease (PD). Although the effects of acute and toxic proteasome inhibition on neural viability are well documented, at present little is known about the effects of chronic low-level proteasome inhibition on neural homeostasis. In order to address this issue we have established clonal lines of neural SH-SY5Y cells, which were generated after continual exposure to low concentrations of a pharmacological proteasome inhibitor. We have recently utilized these clonal cell lines to demonstrate that chronic low-level proteasome inhibition induces neural alterations that are highly relevant to aging, AD, and PD. The focus of this study was to elucidate the alterations in gene expression that occurred in our clonal cell lines after chronic low-level proteasome inhibition. Taken together, data presented in this report indicate that, although chronic low-level proteasome inhibition alters the expression of a limited number of genes (less than 0.8%), it is observed to significantly alter the expression of genes within specific categories that are highly relevant to aging, AD, and PD. Perhaps just as importantly, our analysis revealed that the vast majority of genes altered by chronic low-level proteasome inhibition have not been significantly characterized, suggesting that proteasome inhibition may mediate effects on neural homeostasis through as yet unidentified cellular processes. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
9. The db mutation improves memory in younger mice in a model of Alzheimer's disease.
- Author
-
Zhang, Le, Fernandez-Kim, Sun-Ok, Beckett, Tina L., Niedowicz, Dana M., Kohler, Katharina, Dasuri, Kalavathi, Bruce-Keller, Annadora J., Murphy, M. Paul, and Keller, Jeffrey N.
- Subjects
- *
RAPAMYCIN , *AMYLOID beta-protein precursor , *ALZHEIMER'S disease , *NEUROFIBRILLARY tangles , *TYPE 2 diabetes , *VASCULAR dementia , *MICE - Abstract
Alzheimer's disease (AD) is the most common age-related neurodegenerative disease, while obesity is a major global public health problem associated with the metabolic disorder type 2 diabetes mellitus (T2DM). Chronic obesity and T2DM have been identified as invariant risk factors for dementia and late-onset AD, while their impacts on the occurrence and development of AD remain unclear. As shown in our previous study, the diabetic mutation (db, Lepr db/db ) induces mixed or vascular dementia in mature to middle-aged APP ΔNL/ΔNL x PS1 P264L/P264L knock-in mice (db/AD). In the present study, the impacts of the db mutation on young AD mice at 10 weeks of age were evaluated. The db mutation not only conferred young AD mice with severe obesity, impaired glucose regulation and activated mammalian target of rapamycin (mTOR) signaling pathway in the mouse cortex, but lead to a surprising improvement in memory. At this young age, mice also had decreased cerebral Aβ content, which we have not observed at older ages. This was unlikely to be related to altered Aβ synthesis, as both β- and γ-secretase were unchanged. The db mutation also reduced the cortical IL-1β mRNA level and IBA1 protein level in young AD mice, with no significant effect on the activation of microglia and astrocytes. We conclude that the db mutation could transitorily improve the memory of young AD mice, a finding that may be partially explained by the relatively improved glucose homeostasis in the brains of db/AD mice compared to their counterpart AD mice, suggesting that glucose regulation could be a strategy for prevention and treatment of neurodegenerative diseases like AD. • db mutation caused obesity and metabolic disturbances in 10-week-old AD mice. • db mutation improved memory, decreased cerebral Aβ content of the young AD mice. • db mutation unlikely alter Aβ synthesis and tau pathology in the young AD mice. • db mutation is not associated with neuroinflammation in the young AD mice. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
10. Prolonged diet induced obesity has minimal effects towards brain pathology in mouse model of cerebral amyloid angiopathy: Implications for studying obesity–brain interactions in mice.
- Author
-
Zhang, Le, Dasuri, Kalavathi, Fernandez-Kim, Sun-Ok, Bruce-Keller, Annadora J., Freeman, Linnea R., Pepping, Jennifer K., Beckett, Tina L., Murphy, M. Paul, and Keller, Jeffrey N.
- Subjects
- *
OBESITY , *BRAIN diseases , *LABORATORY mice , *CEREBRAL amyloid angiopathy , *BRAIN physiology , *PATHOLOGY , *NEURODEGENERATION - Abstract
Abstract: Cerebral amyloid angiopathy (CAA) occurs in nearly every individual with Alzheimer's disease (AD) and Down's syndrome, and is the second largest cause of intracerebral hemorrhage. Mouse models of CAA have demonstrated evidence for increased gliosis contributing to CAA pathology. Nearly two thirds of Americans are overweight or obese, with little known about the effects of obesity on the brain, although increasingly the vasculature appears to be a principle target of obesity effects on the brain. In the current study we describe for the first time whether diet induced obesity (DIO) modulates glial reactivity, amyloid levels, and inflammatory signaling in a mouse model of CAA. In these studies we identify surprisingly that DIO does not significantly increase Aβ levels, astrocyte (GFAP) or microglial (IBA-1) gliosis in the CAA mice. However, within the hippocampal gyri a localized increase in reactive microglia were increased in the CA1 and stratum oriens relative to CAA mice on a control diet. DIO was observed to selectively increase IL-6 in CAA mice, with IL-1β and TNF-α not increased in CAA mice in response to DIO. Taken together, these data show that prolonged DIO has only modest effects towards Aβ in a mouse model of CAA, but appears to elevate some localized microglial reactivity within the hippocampal gyri and selective markers of inflammatory signaling. These data are consistent with the majority of the existing literature in other models of Aβ pathology, which surprisingly show a mixed profile of DIO effects towards pathological processes in mouse models of neurodegenerative disease. The importance for considering the potential impact of ceiling effects in pathology within mouse models of Aβ pathogenesis, and the current experimental limitations for DIO in mice to fully replicate metabolic dysfunction present in human obesity, are discussed. This article is part of a Special Issue entitled: Animal Models of Disease. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
11. Leptin regulates amyloid β production via the γ-secretase complex
- Author
-
Niedowicz, Dana M., Studzinski, Christa M., Weidner, Adam M., Platt, Thomas L., Kingry, Kristen N., Beckett, Tina L., Bruce-Keller, Annadora J., Keller, Jeffrey N., and Murphy, M. Paul
- Subjects
- *
LEPTIN regulation , *AMYLOID , *SECRETASES , *ALZHEIMER'S disease , *NEURODEGENERATION - Abstract
Abstract: Alzheimer''s disease (AD) is the most common age-related neurodegenerative disease, affecting an estimated 5.3million people in the United States. While many factors likely contribute to AD progression, it is widely accepted that AD is driven by the accumulation of β-amyloid (Aβ), a small, fibrillogenic peptide generated by the sequential proteolysis of the amyloid precursor protein by the β- and γ-secretases. Though the underlying causes of Aβ accumulation in sporadic AD are myriad, it is clear that lifestyle and overall health play a significant role. The adipocyte-derived hormone leptin has varied systemic affects, including neuropeptide release and neuroprotection. A recent study by Lieb et al. (2009) showed that individuals with low plasma leptin levels are at greater risk of developing AD, through unknown mechanisms. In this report, we show that plasma leptin is a strong negative predictor of Aβ levels in the mouse brain, supporting a protective role for the hormone in AD onset. We also show that the inhibition of Aβ accumulation is due to the downregulation of transcription of the γ-secretase components. On the other hand, β-secretase expression is either unchanged (BACE1) or increased (BACE2). Finally, we show that only presenilin 1 (PS1) is negatively correlated with plasma leptin at the protein level (p<0.0001). These data are intriguing and may highlight a role for leptin in regulating the onset of amyloid pathology and AD. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
12. Increased protein hydrophobicity in response to aging and Alzheimer disease
- Author
-
Dasuri, Kalavathi, Ebenezer, Philip, Zhang, Le, Fernandez-Kim, Sun Ok, Bruce-Keller, Annadora J., Markesbery, William R., and Keller, Jeffrey N.
- Subjects
- *
AGING , *ALZHEIMER'S disease , *PROTEOMICS , *OXIDATIVE stress , *UBIQUITIN , *AFFINITY chromatography , *NEURONS - Abstract
Abstract: Increased levels of misfolded and damaged proteins occur in response to brain aging and Alzheimer disease (AD), which presumably increase the amount of aggregation-prone proteins via elevations in hydrophobicity. The proteasome is an intracellular protease that degrades oxidized and ubiquitinated proteins, and its function is known to be impaired in response to both aging and AD. In this study we sought to determine the potential for increased levels of protein hydrophobicity occurring in response to aging and AD, to identify the contribution of proteasome inhibition to increased protein hydrophobicity, and last to identify the contribution of ubiquitinated and oxidized proteins to the pool of hydrophobic proteins. In our studies we identified that aging and AD brain exhibited increases in protein hydrophobicity as detected using Bis ANS, with dietary restriction (DR) significantly decreasing age-related increases in protein hydrophobicity. Affinity chromatography purification of hydrophobic proteins from aging and AD brains identified increased levels of oxidized and ubiquitinated proteins in the pool of hydrophobic proteins. Pharmacological inhibition of the proteasome in neurons, but not astrocytes, resulted in an increase in protein hydrophobicity. Taken together, these data indicate that there is a relationship between increased protein oxidation and protein ubiquitination and elevations in protein hydrophobicity within the aging and the AD brain, which may be mediated in part by impaired proteasome activity in neurons. Our studies also suggest a potential role for decreased oxidized and hydrophobic proteins in mediating the beneficial effects of DR. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
13. Proteasome Inhibition Alters Neural Mitochondrial Homeostasis and Mitochondria Turnover.
- Author
-
Sullivan, Patrick G., Dragicevic, Natasa B., Deng, Jian-Hong, Bai, Yidong, Dimayuga, Edgardo, Ding, Qunxing, Chen, Qinghua, Bruce-Keller, Annadora J., and Keller, Jeffrey N.
- Subjects
- *
NEURODEGENERATION , *ALZHEIMER'S disease , *PARKINSON'S disease , *MITOCHONDRIAL pathology , *HOMEOSTASIS , *ELECTRON transport , *LIPOFUSCINS - Abstract
Inhibition of proteasome activity occurs in normal aging and in a wide variety of neurodegenerative conditions including Alzheimer's disease and Parkinson's disease. Although each of these conditions is also associated with mitochondrial dysfunction potentially mediated by proteasome inhibition, the relationship between proteasome inhibition and the loss of mitochondrial homeostasis in each of these conditions has not been fully elucidated. In this study, we conducted experimentation in order to begin to develop a more complete understanding of the effects proteasome inhibition has on neural mitochondrial homeostasis. Mitochondria within neural SH-SY5Y cells exposed to low level proteasome inhibition possessed similar morphological features and similar rates of electron transport chain activity under basal conditions as compared with untreated neural cultures of equal passage number. Despite such similarities, maximal complex I and complex II activities were dramatically reduced in neural cells subject to proteasome inhibition. Proteasome inhibition also increased mitochondrial reactive oxygen species production, reduced intramitochondrial protein translation, and increased cellular dependence on glycolysis. Finally, whereas proteasome inhibition generated cells that consistently possessed mitochondria located in close proximity to lysosomes with mitochondria present in the cellular debris located within autophagosomes, increased levels of lipofuscin suggest that impairments in mitochondrial turnover may occur following proteasome inhibition. Taken together, these data demonstrate that proteasome inhibition dramatically alters specific aspects of neural mitochondrial homeostasis and alters lysosomal-mediated degradation of mitochondria with both of these alterations potentially contributing to aging and age-related disease in the nervous system. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.